Frontiers in Oncology | Hematologic Malignancies

Original Research

Published on 17 Mar 2022

Development of a Risk Assessment Model for Early Grade ≥ 3 Infection During the First 3 Months in Patients Newly Diagnosed With Multiple Myeloma Based on a Multicenter, Real-World Analysis in China

in Hematologic Malignancies

Yufeng Shang
Weida Wang
Yuxing Liang
Natasha Mupeta Kaweme
Qian Wang
Minghui Liu
Xiaoqin Chen
Zhongjun Xia
Fuling Zhou

Frontiers in Oncology

doi 10.3389/fonc.2022.772015

3,055 views
9 citations

Original Research

Published on 16 Mar 2022

Acute Myeloid Leukemia Cells Functionally Compromise Hematopoietic Stem/Progenitor Cells Inhibiting Normal Hematopoiesis Through the Release of Extracellular Vesicles

in Hematologic Malignancies

Stefania Trino
Ilaria Laurenzana
Daniela Lamorte
Giovanni Calice
Angelo De Stradis
Michele Santodirocco
Alessandro Sgambato
Antonella Caivano
Luciana De Luca

Frontiers in Oncology

doi 10.3389/fonc.2022.824562

9,891 views
17 citations

Original Research

Published on 16 Mar 2022

Decitabine-Intensified Modified Busulfan/Cyclophosphamide Conditioning Regimen Improves Survival in Acute Myeloid Leukemia Patients Undergoing Related Donor Hematopoietic Stem Cell Transplantation: A Propensity Score Matched Analysis

in Hematologic Malignancies

Ziying Li
Wei Shi
Xuan Lu
Hui Lu
Xiena Cao
Liang Tang
Han Yan
Zhaodong Zhong
Yong You
Linghui Xia

Frontiers in Oncology

doi 10.3389/fonc.2022.844937

3,860 views
17 citations

Systematic Review

Published on 16 Mar 2022

The Coming of Age of Preclinical Models of MDS

in Hematologic Malignancies

Wei Liu
Patric Teodorescu
Stephanie Halene
Gabriel Ghiaur

Frontiers in Oncology

doi 10.3389/fonc.2022.815037

7,590 views
19 citations

Brief Research Report

Published on 14 Mar 2022

Safety of Rapid Daratumumab Infusion: A Retrospective, Multicenter, Real-Life Analysis on 134 Patients With Multiple Myeloma

in Hematologic Malignancies

Francesca Bonello
Serena Rocchi
Gregorio Barilà
Michela Sandrone
Marco Talarico
Elena Zamagni
Matilde Scaldaferri
Susanna Vedovato
Cecilia Bertiond
Laura Pavan

Frontiers in Oncology

doi 10.3389/fonc.2022.851864

5,196 views
15 citations

Original Research

Published on 11 Mar 2022

Efficacy of Intermittent, Oral Famciclovir Prophylaxis for Bortezomib-Induced Herpes Zoster in Multiple Myeloma Patients

in Hematologic Malignancies

Gaofeng Zheng
Fangshu Guan
Xiaoyan Han
Li Yang
Yi Zhao
Yang Yang
Enfang Zhang
Jingsong He
Donghua He
Wenjun Wu

Frontiers in Oncology

doi 10.3389/fonc.2022.843032

4,740 views
6 citations

Original Research

Published on 10 Mar 2022

Identification of a Mitochondria-Related Gene Signature to Predict the Prognosis in AML

in Hematologic Malignancies

Nan Jiang
Xinzhuo Zhang
Qi Chen
Fahsai Kantawong
Shengli Wan
Jian Liu
Hua Li
Jie Zhou
Bin Lu
Jianming Wu

Frontiers in Oncology

doi 10.3389/fonc.2022.823831

8,908 views
18 citations

Original Research

Published on 10 Mar 2022

Methylation of SPRED1: A New Target in Acute Myeloid Leukemia

in Hematologic Malignancies

Nan Su
Yujiao Wang
Xianglan Lu
Weihong Xu
He Wang
Wenbin Mo
Hui Pang
Rurong Tang
Shibo Li
Xiaojing Yan

Frontiers in Oncology

doi 10.3389/fonc.2022.854192

3,593 views
4 citations

Original Research

Published on 10 Mar 2022

Trends in Disease Burden of Chronic Lymphocytic Leukemia at the Global, Regional, and National Levels From 1990 to 2019, and Projections Until 2030: A Population-Based Epidemiologic Study

in Hematologic Malignancies

Yang Ou
Yichen Long
Lili Ji
Yanxia Zhan
Tiankui Qiao
Xiangdong Wang
Hao Chen
Yunfeng Cheng

Frontiers in Oncology

doi 10.3389/fonc.2022.840616

19,559 views
65 citations

Editorial

Published on 10 Mar 2022

Editorial: Molecular Mechanisms of Multiple Myeloma

in Hematologic Malignancies

Alessandro Gozzetti
Chung Hoow Kok
Chien-Feng Li

Frontiers in Oncology

doi 10.3389/fonc.2022.870123

2,923 views
1 citation

Review

Published on 10 Mar 2022

Cytokines in the Pathogenesis of Large Granular Lymphocytic Leukemia

in Hematologic Malignancies

Colleen Isabelle
Amy Boles
Nitin Chakravarti
Pierluigi Porcu
Jonathan Brammer
Anjali Mishra

Frontiers in Oncology

doi 10.3389/fonc.2022.849917

5,473 views
17 citations

Mini Review

Published on 09 Mar 2022

Mature T-Cell leukemias: Challenges in Diagnosis

in Hematologic Malignancies

Dima El-Sharkawi
Ayoma Attygalle
Claire Dearden

Frontiers in Oncology

doi 10.3389/fonc.2022.777066

9,314 views
9 citations

Review

Published on 09 Mar 2022

Antigen-Specific TCR-T Cells for Acute Myeloid Leukemia: State of the Art and Challenges

in Hematologic Malignancies

Synat Kang
Yisheng Li
Jingqiao Qiao
Xiangyu Meng
Ziqian He
Xuefeng Gao
Li Yu

Frontiers in Oncology

doi 10.3389/fonc.2022.787108

11,271 views
20 citations

Review

Published on 09 Mar 2022

Lessons From Pediatric MDS: Approaches to Germline Predisposition to Hematologic Malignancies

in Hematologic Malignancies

Serine Avagyan
Akiko Shimamura

Frontiers in Oncology

doi 10.3389/fonc.2022.813149

9,160 views
26 citations

Mini Review

Published on 09 Mar 2022

Risk Stratification Before and During Treatment in Newly Diagnosed Multiple Myeloma: From Clinical Trials to the Real-World Setting

in Hematologic Malignancies

Francesca Bonello
Lorenzo Cani
Mattia D’Agostino

Frontiers in Oncology

doi 10.3389/fonc.2022.830922

7,505 views
18 citations

Case Report

Published on 08 Mar 2022

Case Report: Free-Floating Intracoronary Thrombus: Who Is the Convict?

in Hematologic Malignancies

Francesca Mantovani
Ambra Paolini
Andrea Barbieri
Giuseppe Boriani

Frontiers in Oncology

doi 10.3389/fonc.2022.825711

1,817 views
1 citation

Original Research

Published on 07 Mar 2022

Management of Chronic Myeloid Leukemia and Pregnancy: A Bibliometric Analysis (2000-2020)

in Hematologic Malignancies

Yue Wang
Liqing Jiang
Baoxuan Li
Yan Zhao

Frontiers in Oncology

doi 10.3389/fonc.2022.826703

9,355 views
17 citations

Editorial

Published on 07 Mar 2022

Editorial: Cellular and Molecular Mechanisms of Immune Checkpoint Blockers in Anti-leukemia/Lymphoma Immune Therapy

in Hematologic Malignancies

Mazdak Ganjalikhani-Hakemi
Ling Xu
Andrey A. Zamyatnin
Alexandr V. Bazhin

Frontiers in Oncology

doi 10.3389/fonc.2022.872300

1,674 views
1 citation

Case Report

Published on 04 Mar 2022

Acute Promyelocytic Leukemia Presenting With a Myeloid Sarcoma of the Spine: A Case Report and Literature Review

in Hematologic Malignancies

Xuemei Shu
Qiuling Wu
Tao Guo
Hua Yin
Jingdi Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.851406

4,327 views
10 citations

Original Research

Published on 03 Mar 2022

Treatment-Free Remission in Chronic Myeloid Leukemia Patients Treated With Low-Dose TKIs: A Feasible Option Also in the Real-Life. A Campus CML Study

in Hematologic Malignancies

Alessandra Iurlo
Daniele Cattaneo
Silvia Artuso
Dario Consonni
Elisabetta Abruzzese
Gianni Binotto
Monica Bocchia
Massimiliano Bonifacio
Fausto Castagnetti
Sara Galimberti

Frontiers in Oncology

doi 10.3389/fonc.2022.839915

7,002 views
17 citations

Original Research

Published on 01 Mar 2022

Critical Role of Flow Cytometric Immunophenotyping in the Diagnosis, Subtyping, and Staging of T-Cell/NK-Cell Non-Hodgkin’s Lymphoma in Real-World Practice: A Study of 232 Cases From a Tertiary Cancer Center in India

in Hematologic Malignancies

Prashant R. Tembhare
Gaurav Chatterjee
Anumeha Chaturvedi
Niharika Dasgupta
Twinkle Khanka
Shefali Verma
Sitaram G. Ghogale
Nilesh Deshpande
Karishma Girase
Manju Sengar

Frontiers in Oncology

doi 10.3389/fonc.2022.779230

19,251 views
16 citations

Original Research

Published on 28 Feb 2022

A Novel Risk Defining System for Pediatric T-Cell Acute Lymphoblastic Leukemia From CCCG-ALL-2015 Group

in Hematologic Malignancies

Xiaoming Liu
Yao Zou
Li Zhang
Ye Guo
Yumei Chen
Wenyu Yang
Xiaojuan Chen
Shuchun Wang
Yingchi Zhang
Min Ruan

Frontiers in Oncology

doi 10.3389/fonc.2022.841179

4,807 views
12 citations

Original Research

Published on 28 Feb 2022

Real-World Estimation of First- and Second-Line Treatments for Diffuse Large B-Cell Lymphoma Using Health Insurance Data: A Belgian Population-Based Study

in Hematologic Malignancies

Willem Daneels
Michael Rosskamp
Gilles Macq
Estabraq Ismael Saadoon
Anke De Geyndt
Fritz Offner
Hélène A. Poirel

Frontiers in Oncology

doi 10.3389/fonc.2022.824704

8,271 views
15 citations

Original Research

Published on 28 Feb 2022

Serum Abnormal Metabolites for Evaluating Therapeutic Response and Prognosis of Patients With Multiple Myeloma

in Hematologic Malignancies

Yujun Wei
Jinying Wang
Fei Chen
Xin Li
Jiajia Zhang
Man Shen
Ran Tang
Zhongxia Huang

Frontiers in Oncology

doi 10.3389/fonc.2022.808290

3,872 views
13 citations

2,059 articles

articles

Development of a Risk Assessment Model for Early Grade ≥ 3 Infection During the First 3 Months in Patients Newly Diagnosed With Multiple Myeloma Based on a Multicenter, Real-World Analysis in China

Acute Myeloid Leukemia Cells Functionally Compromise Hematopoietic Stem/Progenitor Cells Inhibiting Normal Hematopoiesis Through the Release of Extracellular Vesicles

Decitabine-Intensified Modified Busulfan/Cyclophosphamide Conditioning Regimen Improves Survival in Acute Myeloid Leukemia Patients Undergoing Related Donor Hematopoietic Stem Cell Transplantation: A Propensity Score Matched Analysis

The Coming of Age of Preclinical Models of MDS

Safety of Rapid Daratumumab Infusion: A Retrospective, Multicenter, Real-Life Analysis on 134 Patients With Multiple Myeloma

Efficacy of Intermittent, Oral Famciclovir Prophylaxis for Bortezomib-Induced Herpes Zoster in Multiple Myeloma Patients

Identification of a Mitochondria-Related Gene Signature to Predict the Prognosis in AML

Methylation of SPRED1: A New Target in Acute Myeloid Leukemia

Trends in Disease Burden of Chronic Lymphocytic Leukemia at the Global, Regional, and National Levels From 1990 to 2019, and Projections Until 2030: A Population-Based Epidemiologic Study

Editorial: Molecular Mechanisms of Multiple Myeloma

Cytokines in the Pathogenesis of Large Granular Lymphocytic Leukemia

Mature T-Cell leukemias: Challenges in Diagnosis

Antigen-Specific TCR-T Cells for Acute Myeloid Leukemia: State of the Art and Challenges

Lessons From Pediatric MDS: Approaches to Germline Predisposition to Hematologic Malignancies

Risk Stratification Before and During Treatment in Newly Diagnosed Multiple Myeloma: From Clinical Trials to the Real-World Setting

Case Report: Free-Floating Intracoronary Thrombus: Who Is the Convict?

Management of Chronic Myeloid Leukemia and Pregnancy: A Bibliometric Analysis (2000-2020)

Editorial: Cellular and Molecular Mechanisms of Immune Checkpoint Blockers in Anti-leukemia/Lymphoma Immune Therapy

Acute Promyelocytic Leukemia Presenting With a Myeloid Sarcoma of the Spine: A Case Report and Literature Review

Treatment-Free Remission in Chronic Myeloid Leukemia Patients Treated With Low-Dose TKIs: A Feasible Option Also in the Real-Life. A Campus CML Study

Critical Role of Flow Cytometric Immunophenotyping in the Diagnosis, Subtyping, and Staging of T-Cell/NK-Cell Non-Hodgkin’s Lymphoma in Real-World Practice: A Study of 232 Cases From a Tertiary Cancer Center in India

A Novel Risk Defining System for Pediatric T-Cell Acute Lymphoblastic Leukemia From CCCG-ALL-2015 Group

Real-World Estimation of First- and Second-Line Treatments for Diffuse Large B-Cell Lymphoma Using Health Insurance Data: A Belgian Population-Based Study

Serum Abnormal Metabolites for Evaluating Therapeutic Response and Prognosis of Patients With Multiple Myeloma